Applied Therapeutics

About:

Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.

Website: http://www.appliedtherapeutics.com/

Twitter/X: applied_tx

Top Investors: Perceptive Advisors, Alexandria Venture Investments, Janus Henderson Investors, Frazier Life Sciences, Rock Springs Capital

Description:

Applied Therapeutics operates as a biotechnology company. The company focuses on developing transformative drugs in areas of high unmet medical need -fatal and debilitating diseases for which no therapies are approved. The company is developing a pipeline of novel product candidates against previously validated and well-known molecular targets. It uses technological advances and abbreviated regulatory pathways, wherever possible, to design drugs for indications of significant unmet medical needs.

Total Funding Amount:

$419M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)appliedtherapeutics.com

Founders:

Shoshana Shendelman

Number of Employees:

11-50

Last Funding Date:

2024-02-27

IPO Status:

Public

© 2025 bioDAO.ai